US Drug Recall Register
Class II · Moderate risk Completed Initiated Dec 20, 2018 (8 years ago)

OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP Deviations: A silicone particulate was noted in Ozurdex.

What was recalled

OZURDEX (dexamethasone intravitreal implant) 0.7 mg), 1 single-use plastic applicator contained within carton, Rx only, Allergan Inc Irvine, CA 92612, NDC 0023-3348-07

Recalling firm
Allergan, PLC.
NDC code
0023-3348-07
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0387-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Dexamethasone recalls

See all